CompletedNot applicableNCT03986671

Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Powell Mansfield Inc.
Principal Investigator
Perry Mansfield, MD
Perry Mansfield MD Inc.
Intervention
Transmembrane EMG Oropharynx Probe(device)
Enrollment
50 enrolled
Eligibility
18-70 years · All sexes
Timeline
20192021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03986671 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials